Survey Demonstrates Implicit Bias Toward Cervical Cancer Diagnoses Among Nurses, Women
Survey sought to assess the relative implicit biases of gynecologic healthcare providers regarding women with diagnoses of cervical vs ovarian cancer.
Ovarian Cancer
Imported Doxorubicin Similar to US FDA-Approved Brand in Relapsed/Refractory Ovarian Cancer
This retrospective analysis determined the effect of Doxil vs Lipodox brands of doxorubicin, used for the treatment of recurrent or refractory ovarian cancer.
Low-Dose Aspirin May Lower Ovarian Cancer Risk
Inverse association for low-dose but not standard-dose aspirin with ovarian cancer risk.
Use of Anti-inflammatory Analgesics Has a Positive Effect on Survival Outcomes in Ovarian Cancer
The use of anti-inflammatory analgesics, such as aspirin, may extend survival for patients with ovarian cancer.
Adding Bevacizumab to First-line Chemotherapy Benefits Selects Cases of Ovarian Cancer
Researchers conducted a retrospective analysis to determine the impact of inflammatory responses in patients with ovarian cancer undergoing first-line chemotherapy with or without bevacizumab.
Link Between Asbestos-Free Talcum Powder and Cancer Unclear
Studies conducted in people have mixed results, with some indication of increased risk of ovarian cancer.
Long-Term Benefits Seen With Trabectedin With PLD for Recurrent Ovarian Cancer
Researchers conducted a prospective real-life analysis to determine the effects of trabectedin plus PLD in patients with platinum-sensitive recurrent ovarian cancer.
Are Ovarian Cancer Stem Cells the Target for Innovative Immunotherapy?
[OncoTargets and Therapy] In a review of cancer stem cells (CSCs)/ovarian cancer stem cells (OCSCs), researchers discuss the implications of immunotherapy development based on studying cancer evolution by CSCs, and targeting OCSC surface markers to develop CAR-T immunotherapy.
Severe Folate Deficiency Associated With Olaparib for Relapsed Ovarian Cancer
In a case study, olaparib was found to induce folate deficiency in most patients with relapsed ovarian cancer. Researchers discuss the significance of this adverse effect and how it was managed.
Primary Cytoreductive Surgery for HGSC Offers Better Survival Than Neoadjuvant Chemotherapy
Researchers conducted a retrospective cohort analysis to examine patterns of clinical practice in the management of women with advanced HGSC.
Next post in Ovarian Cancer
